Answer
Mylotarg (gemtuzumab ozogamicin) is contraindicated in patients with hypersensitivity to gemtuzumab ozogamicin or any excipient listed in section 6.1 of its product information.
Sources for this answer
- MYLOTARG 5mg powder for concentrate for solution for infusionPfizer Limited · emc · SmPC §4.3 Contraindications · Version 13Document updated
Sources checked